German Center for Neurodegenrative Diseases (DZNE, Munich):

https://www.dzne.de/en/sites/munich.html
The collaboration with DZNE, Munich is coordinated through Translational Neurodegeneration Department. For five years MERC and DZNE has been involved in DAAD funded projects to characterize genetic and epidemiological factors controlling Parkinson’s disease.

Department of Pharmacology and Cancer Biology, Duke University Medical Center:
http://pcb.duke.edu/
For about four years, MERC in collaboration with Pharmacology and Cancer Biology, Duke University, are trying to develop new biomarkers for diagnosis of brain damage. The collaboration has been generously funded by IBRO, ISN, Mansoura University Competitive Grants Program and Academy of Scientific Research and Technology (ASRT).

Luxembourg Center for Systems Bioscience (LCSB):
http://wwwen.uni.lu/lcsb
LCSB and MERC are currently involved in establishment of a new bioinformatic center and integrated biobank for future application in research in the biomedical field.

Genetic Epidemiology of Parkinson’s Disease (GEoPD):
http://geopd.can.ubc.ca/
MERC is currently the newest member of GeoPD and is considered the first member in the Middle East. The main goal of this collaboration is to identify novel environmental and genetic risk factors for PD in Africa.

Department of Chemical Engineering, Northeastern University, USA:
http://www.che.neu.edu/che/about-chemical-engineering
This collaboration aims to explore the possibility of applying nanotechnology in regenerative Medicine.

Global Brain Health Institute (GBHI) USA
http://www.gbhi.org/
Aiming at fighting dementia worldwide

Hokkaido University, Japan
http://www2.hokkyodai.ac.jp/english/
Aiming at studying the immunogenetic profiles for Parkinson’s patients derived fibroblasts

IBRO-MENA:
MERC was chosen as IBRO MENA center of excellence in Egypt. For training and education of students from Middle East
- Lubek – University Germany